In a filing, Rani Therapeutics Holdings Inc revealed its Director IMRAN MIR A acquired Company’s shares for reported $1.26 million on Oct 23 ’25. In the deal valued at $0.60 per share,2,083,334 shares were bought. As a result of this transaction, IMRAN MIR A now holds 2,083,334 shares worth roughly $3.71 million.
Then, South Cone Investments Limited sold 4,000,000 shares, generating $11,074,000 in total proceeds. Upon selling the shares at $2.77, the 10% Owner now owns 2,379,194 shares.
Before that, South Cone Investments Limited sold 1,923,000 shares. Rani Therapeutics Holdings Inc shares valued at $4,637,314 were divested by the 10% Owner at a price of $2.41 per share. As a result of the transaction, South Cone Investments Limited now holds 6,379,194 shares, worth roughly $11.35 million.
Oppenheimer initiated its Rani Therapeutics Holdings Inc [RANI] rating to an Outperform in a research note published on August 02, 2024; the price target was $17. A number of analysts have revised their coverage, including Maxim Group’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Rodman & Renshaw began covering RANI with “Buy” recommendation on June 13, 2024.
Price Performance Review of RANI
On Monday, Rani Therapeutics Holdings Inc [NASDAQ:RANI] saw its stock fall -2.20% to $1.78. Over the last five days, the stock has lost -20.89%. Rani Therapeutics Holdings Inc shares have fallen nearly -29.37% since the year began. Nevertheless, the stocks have risen 29.93% over the past one year. While a 52-week high of $3.87 was reached on 10/22/25, a 52-week low of $0.39 was recorded on 07/15/25.
Levels Of Support And Resistance For RANI Stock
The 24-hour chart illustrates a support level at 1.6500, which if violated will result in even more drops to 1.5200. On the upside, there is a resistance level at 2.0400. A further resistance level may holdings at 2.3000.
How much short interest is there in Rani Therapeutics Holdings Inc?
A steep rise in short interest was recorded in Rani Therapeutics Holdings Inc stocks on 2025-10-15, growing by 54799.0 shares to a total of 0.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 63982.0 shares. There was a rise of 46.13%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2022 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $15 price target.
